ArticleScientific reports2026
Radiomics-based fundus autofluorescence analysis in central serous chorioretinopathy-MICRoN report number twelve.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
This study applies radiomics-based feature extraction to fundus autofluorescence (FAF) images to automatically identify quantitative biomarkers that distinguish simple versus complex and acute versus chronic subtypes of central serous chorioretinopathy (CSCR). A total of 96 FAF images representing different CSCR stages were analyzed: simple (n = 47), complex (n = 49), acute (n = 47), and chronic (n = 49). Fifty-two radiomic features were extracted from the entire 55° FAF images using Pyfeats. Variables with zero variance and highly correlated features (Pearson's r > 0.8) were excluded. The most informative features were identified and used to construct and evaluate logistic regression, random forest, and extreme gradient boosting (XGBoost) classifiers for CSCR stage prediction. For simple versus complex CSCR, eight selected features yielded excellent discriminative performance in the logistic regression model, with a mean area under the receiver operating characteristic curve (AUC) of 0.90 (95% CI, 0.71-1.00) and an accuracy of 0.80. Sensitivity and specificity were balanced at 0.80 each, indicating robust and stable classification performance. For acute versus chronic CSCR, ten features were selected. The XGBoost model demonstrated modest discriminative ability with a mean AUC of 0.69 (95% CI, 0.39-0.98) and an accuracy of 0.71, with balanced sensitivity (0.70) and specificity (0.71) across resamples. Radiomic features extracted from FAF images effectively distinguish simple and complex CSCR, supporting their potential as quantitative imaging biomarkers for automated CSCR classification and disease staging.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.